Franklin Resources
AMLX icon

Franklin Resources’s Amylyx Pharmaceuticals AMLX Stock Holding History

Franklin Resources’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.4M Buy
2,261,569
+1,061,473
+88% +$14.9M 0.01% 800
2025
Q4 		$14.5M Buy
+1,200,096
New +$16.3M ﹤0.01% 1053
2024
Q2 		– Sell
-1,855,886
Closed -$5.27M – 2869
2024
Q1 		$5.27M Buy
1,855,886
+530,885
+40% +$6.94M ﹤0.01% 1305
2023
Q4 		$19.5M Buy
1,325,001
+707,134
+114% +$10.8M 0.01% 759
2023
Q3 		$11.3M Buy
617,867
+589,381
+2,069% +$12.5M 0.01% 886
2023
Q2 		$614K Buy
+28,486
New +$769K ﹤0.01% 1882

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Franklin Resources's AMLX Position: Q1 2026 in Review

Franklin Resources increased its Amylyx Pharmaceuticals (AMLX) stake by 88% in Q1 2026, buying an estimated $14.9M and bringing the position to 2,261,569 shares worth $31.4M. The position accounts for 0.01% of the portfolio, ranked #800.

Franklin Resources first reported a position in AMLX in Q2 2023 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Franklin Resources held 2,261,569 shares of Amylyx Pharmaceuticals worth $31.4M as of Q1 2026.
  • Franklin Resources bought 1,061,473 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $14.9M.
  • Amylyx Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q1 2026, its #800 holding.
  • Franklin Resources first reported a position in Amylyx Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.